{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T05:31:01Z","timestamp":1790400661804,"version":"4.1.0"},"reference-count":77,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,8,22]],"date-time":"2025-08-22T00:00:00Z","timestamp":1755820800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,8,22]],"date-time":"2025-08-22T00:00:00Z","timestamp":1755820800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-03857-0","type":"journal-article","created":{"date-parts":[[2025,8,22]],"date-time":"2025-08-22T14:27:38Z","timestamp":1755872858000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Non-canonical Gq activation by orexin receptor type 2 and lemborexant observed in microsecond molecular dynamics simulations"],"prefix":"10.1038","volume":"15","author":[{"given":"Paulina","family":"Dragan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valerie","family":"Gratio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thierry","family":"Voisin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2912-5168","authenticated-orcid":false,"given":"Alain","family":"Couvineau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0429-0637","authenticated-orcid":false,"given":"Dorota","family":"Latek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,8,22]]},"reference":[{"issue":"5","key":"3857_CR1","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1124\/pharmrev.123.000953","volume":"76","author":"JP Kukkonen","year":"2024","unstructured":"Kukkonen, J. P., Jacobson, L. H., Hoyer, D., Rinne, M. K. & Borgland, S. L. International union of basic and clinical pharmacology CXIV: Orexin receptor function, nomenclature and pharmacology. Pharmacol. Rev. 76(5), 625\u2013688. https:\/\/doi.org\/10.1124\/pharmrev.123.000953 (2024).","journal-title":"Pharmacol. Rev."},{"issue":"1","key":"3857_CR2","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1073\/pnas.95.1.322","volume":"95","author":"L de Lecea","year":"1998","unstructured":"de Lecea, L. et al. The hypocretins: Hypothalamus-specific peptides with neuroexcitatory activity. Proc. Natl. Acad. Sci. 95(1), 322\u2013327. https:\/\/doi.org\/10.1073\/pnas.95.1.322 (1998).","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"4","key":"3857_CR3","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1016\/S0092-8674(00)80949-6","volume":"92","author":"T Sakurai","year":"1998","unstructured":"Sakurai, T. et al. Orexins and orexin receptors: a family of hypothalamic neuropeptides and G Protein-coupled receptors that regulate feeding behavior. Cell 92(4), 573\u2013585. https:\/\/doi.org\/10.1016\/S0092-8674(00)80949-6 (1998).","journal-title":"Cell"},{"issue":"08","key":"3857_CR4","doi-asserted-by":"publisher","first-page":"1399","DOI":"10.5664\/jcsm.7282","volume":"14","author":"K Janto","year":"2018","unstructured":"Janto, K., Prichard, J. R. & Pusalavidyasagar, S. An update on dual orexin receptor antagonists and their potential role in insomnia therapeutics. J. Clin. Sleep Med. 14(08), 1399\u20131408. https:\/\/doi.org\/10.5664\/jcsm.7282 (2018).","journal-title":"J. Clin. Sleep Med."},{"key":"3857_CR5","doi-asserted-by":"publisher","first-page":"573","DOI":"10.3389\/fendo.2018.00573","volume":"9","author":"A Couvineau","year":"2018","unstructured":"Couvineau, A. et al. The anti-tumoral properties of orexin\/hypocretin hypothalamic neuropeptides: an unexpected therapeutic role. Front. Endocrinol. 9, 573. https:\/\/doi.org\/10.3389\/fendo.2018.00573 (2018).","journal-title":"Front. Endocrinol."},{"issue":"4","key":"3857_CR6","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1016\/S0092-8674(00)81973-X","volume":"98","author":"RM Chemelli","year":"1999","unstructured":"Chemelli, R. M. et al. Narcolepsy in orexin knockout mice: molecular genetics of sleep regulation. Cell 98(4), 437\u2013451. https:\/\/doi.org\/10.1016\/S0092-8674(00)81973-X (1999).","journal-title":"Cell"},{"issue":"2","key":"3857_CR7","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1002\/1097-4547(20001015)62:2<161::AID-JNR1>3.0.CO;2-1","volume":"62","author":"JG Sutcliffe","year":"2000","unstructured":"Sutcliffe, J. G. & de Lecea, L. The hypocretins: Excitatory neuromodulatory peptides for multiple homeostatic systems, including sleep and feeding. J. Neurosci. Res. 62(2), 161\u2013168 (2000).","journal-title":"J. Neurosci. Res."},{"issue":"4","key":"3857_CR8","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1111\/j.1748-1716.2008.01836.x","volume":"192","author":"MV Heinonen","year":"2008","unstructured":"Heinonen, M. V., Purhonen, A. K., M\u00e4kel\u00e4, K. A. & Herzig, K. H. Functions of orexins in peripheral tissues. Acta Physiol. 192(4), 471\u2013485. https:\/\/doi.org\/10.1111\/j.1748-1716.2008.01836.x (2008).","journal-title":"Acta Physiol."},{"issue":"11","key":"3857_CR9","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1038\/nrn3837","volume":"15","author":"T Sakurai","year":"2014","unstructured":"Sakurai, T. The role of orexin in motivated behaviours. Nat. Rev. Neurosci. 15(11), 719\u2013731. https:\/\/doi.org\/10.1038\/nrn3837 (2014).","journal-title":"Nat. Rev. Neurosci."},{"issue":"6","key":"3857_CR10","doi-asserted-by":"publisher","first-page":"1678","DOI":"10.1111\/j.1476-5381.2011.01510.x","volume":"165","author":"M Laburthe","year":"2012","unstructured":"Laburthe, M. & Voisin, T. The orexin receptor OX1R in colon cancer: A promising therapeutic target and a new paradigm in G protein-coupled receptor signalling through ITIMs. Br. J. Pharmacol. 165(6), 1678\u20131687. https:\/\/doi.org\/10.1111\/j.1476-5381.2011.01510.x (2012).","journal-title":"Br. J. Pharmacol."},{"issue":"3","key":"3857_CR11","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1124\/jpet.115.225466","volume":"354","author":"P Bonaventure","year":"2015","unstructured":"Bonaventure, P. et al. Characterization of JNJ-42847922, a selective orexin-2 receptor antagonist, as a clinical candidate for the treatment of insomnia. J. Pharmacol. Exp. Ther. 354(3), 471\u2013482. https:\/\/doi.org\/10.1124\/jpet.115.225466 (2015).","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"6","key":"3857_CR12","doi-asserted-by":"publisher","first-page":"898","DOI":"10.1002\/cmdc.201300003","volume":"8","author":"MA Steiner","year":"2013","unstructured":"Steiner, M. A. et al. Discovery and characterization of ACT-335827, an orally available, brain penetrant orexin receptor type 1 selective antagonist. ChemMedChem 8(6), 898\u2013903. https:\/\/doi.org\/10.1002\/cmdc.201300003 (2013).","journal-title":"ChemMedChem"},{"issue":"1","key":"3857_CR13","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1017\/S1461145713000552","volume":"17","author":"A Pa\u0142asz","year":"2014","unstructured":"Pa\u0142asz, A. et al. Dual orexin receptor antagonists\u2014promising agents in the treatment of sleep disorders. Int. J. Neuropsychopharmacol. 17(1), 157\u2013168. https:\/\/doi.org\/10.1017\/S1461145713000552 (2014).","journal-title":"Int. J. Neuropsychopharmacol."},{"issue":"2","key":"3857_CR14","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1111\/bph.12324","volume":"171","author":"JP Kukkonen","year":"2014","unstructured":"Kukkonen, J. P. & Leonard, C. S. Orexin\/hypocretin receptor signalling cascades. Br. J. Pharmacol. 171(2), 314\u2013331. https:\/\/doi.org\/10.1111\/bph.12324 (2014).","journal-title":"Br. J. Pharmacol."},{"key":"3857_CR15","doi-asserted-by":"publisher","unstructured":"Gratio, V., Dragan, P., Garcia, L., Saveanu, L., Nicole, P., Voisin, T., Latek, D., & Couvineau, A. (2024). Pharmacodynamics of the orexin type 1 (OX1) receptor in colon cancer cell models: A two\u2010sided nature of antagonistic ligands resulting from partial dissociation of Gq. Br. J. Pharmacol. bph.17422. https:\/\/doi.org\/10.1111\/bph.17422","DOI":"10.1111\/bph.17422"},{"issue":"8","key":"3857_CR16","doi-asserted-by":"publisher","first-page":"1366","DOI":"10.1039\/C003468A","volume":"6","author":"T Kodadek","year":"2010","unstructured":"Kodadek, T. & Cai, D. Chemistry and biology of orexin signaling. Mol. BioSyst. 6(8), 1366\u20131375. https:\/\/doi.org\/10.1039\/C003468A (2010).","journal-title":"Mol. BioSyst."},{"issue":"10","key":"3857_CR17","doi-asserted-by":"publisher","first-page":"2693","DOI":"10.1007\/s00213-021-05954-0","volume":"238","author":"C Roch","year":"2021","unstructured":"Roch, C., Bergamini, G., Steiner, M. A. & Clozel, M. Nonclinical pharmacology of daridorexant: A new dual orexin receptor antagonist for the treatment of insomnia. Psychopharmacology 238(10), 2693\u20132708. https:\/\/doi.org\/10.1007\/s00213-021-05954-0 (2021).","journal-title":"Psychopharmacology"},{"issue":"1","key":"3857_CR18","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.smrv.2006.06.002","volume":"11","author":"T Roth","year":"2007","unstructured":"Roth, T., Roehrs, T. & Pies, R. Insomnia: Pathophysiology and implications for treatment. Sleep Med. Rev. 11(1), 71\u201379. https:\/\/doi.org\/10.1016\/j.smrv.2006.06.002 (2007).","journal-title":"Sleep Med. Rev."},{"issue":"16","key":"3857_CR19","doi-asserted-by":"publisher","first-page":"Article 16","DOI":"10.3390\/molecules26164849","volume":"26","author":"A Couvineau","year":"2021","unstructured":"Couvineau, A., Nicole, P., Gratio, V. & Voisin, T. Orexins\/hypocretins and cancer: A neuropeptide as emerging target. Molecules 26(16), Article 16. https:\/\/doi.org\/10.3390\/molecules26164849 (2021).","journal-title":"Molecules"},{"key":"3857_CR20","doi-asserted-by":"publisher","first-page":"1096159","DOI":"10.3389\/fphar.2023.1096159","volume":"14","author":"S Yang","year":"2023","unstructured":"Yang, S. et al. Multiomics integration reveals the effect of Orexin A on glioblastoma. Front. Pharmacol. 14, 1096159. https:\/\/doi.org\/10.3389\/fphar.2023.1096159 (2023).","journal-title":"Front. Pharmacol."},{"issue":"10","key":"3857_CR21","doi-asserted-by":"publisher","first-page":"4977","DOI":"10.1210\/en.2006-0201","volume":"147","author":"T Voisin","year":"2006","unstructured":"Voisin, T., Firar, A. E., Avondo, V. & Laburthe, M. Orexin-induced apoptosis: The key role of the seven-transmembrane domain orexin type 2 receptor. Endocrinology 147(10), 4977\u20134984. https:\/\/doi.org\/10.1210\/en.2006-0201 (2006).","journal-title":"Endocrinology"},{"issue":"9","key":"3857_CR22","doi-asserted-by":"publisher","first-page":"3341","DOI":"10.1158\/0008-5472.CAN-10-3473","volume":"71","author":"T Voisin","year":"2011","unstructured":"Voisin, T. et al. Aberrant expression of OX1 receptors for orexins in colon cancers and liver metastases: An openable gate to apoptosis. Can. Res. 71(9), 3341\u20133351. https:\/\/doi.org\/10.1158\/0008-5472.CAN-10-3473 (2011).","journal-title":"Can. Res."},{"key":"3857_CR23","doi-asserted-by":"publisher","unstructured":"Dayot, S., et al. In vitro, in vivo and ex vivo demonstration of the antitumoral role of hypocretin-1\/orexin-A and almorexant in pancreatic ductal adenocarcinoma. Oncotarget. 9(6), 6952\u20136967. https:\/\/doi.org\/10.18632\/oncotarget.24084 (2018).","DOI":"10.18632\/oncotarget.24084"},{"issue":"1","key":"3857_CR24","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1038\/s41467-021-21087-6","volume":"12","author":"C Hong","year":"2021","unstructured":"Hong, C. et al. Structures of active-state orexin receptor 2 rationalize peptide and small-molecule agonist recognition and receptor activation. Nat. Commun. 12(1), 815. https:\/\/doi.org\/10.1038\/s41467-021-21087-6 (2021).","journal-title":"Nat. Commun."},{"issue":"4","key":"3857_CR25","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1007\/s40265-020-01276-1","volume":"80","author":"LJ Scott","year":"2020","unstructured":"Scott, L. J. Lemborexant: First approval. Drugs 80(4), 425\u2013432. https:\/\/doi.org\/10.1007\/s40265-020-01276-1 (2020).","journal-title":"Drugs"},{"issue":"6","key":"3857_CR26","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1016\/j.neuron.2018.08.011","volume":"99","author":"SA Hollingsworth","year":"2018","unstructured":"Hollingsworth, S. A. & Dror, R. O. Molecular dynamics simulation for all. Neuron 99(6), 1129\u20131143. https:\/\/doi.org\/10.1016\/j.neuron.2018.08.011 (2018).","journal-title":"Neuron"},{"issue":"14","key":"3857_CR27","doi-asserted-by":"publisher","first-page":"7898","DOI":"10.1021\/acs.chemrev.6b00163","volume":"116","author":"S Kmiecik","year":"2016","unstructured":"Kmiecik, S. et al. Coarse-grained protein models and their applications. Chem. Rev. 116(14), 7898\u20137936. https:\/\/doi.org\/10.1021\/acs.chemrev.6b00163 (2016).","journal-title":"Chem. Rev."},{"issue":"3","key":"3857_CR28","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1208\/s12248-015-9742-8","volume":"17","author":"Z Feng","year":"2015","unstructured":"Feng, Z., Ma, S., Hu, G. & Xie, X.-Q. Allosteric binding site and activation mechanism of class C G-protein coupled receptors: metabotropic glutamate receptor family. AAPS J. 17(3), 737\u2013753. https:\/\/doi.org\/10.1208\/s12248-015-9742-8 (2015).","journal-title":"AAPS J."},{"issue":"30","key":"3857_CR29","doi-asserted-by":"publisher","first-page":"6462","DOI":"10.1021\/acs.jpcb.9b04867","volume":"123","author":"J Wang","year":"2019","unstructured":"Wang, J. & Miao, Y. Mechanistic insights into specific G protein interactions with adenosine receptors. J. Phys. Chem. B 123(30), 6462\u20136473. https:\/\/doi.org\/10.1021\/acs.jpcb.9b04867 (2019).","journal-title":"J. Phys. Chem. B"},{"issue":"7","key":"3857_CR30","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pcbi.1009994","volume":"18","author":"S Wisniewski","year":"2022","unstructured":"Wisniewski, S., Dragan, P., Makal, A. & Latek, D. Helix 8 in chemotactic receptors of the complement system. PLoS Comput. Biol. 18(7), e1009994. https:\/\/doi.org\/10.1371\/journal.pcbi.1009994 (2022).","journal-title":"PLoS Comput. Biol."},{"issue":"8","key":"3857_CR31","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1038\/s41592-020-0884-y","volume":"17","author":"I Rodr\u00edguez-Espigares","year":"2020","unstructured":"Rodr\u00edguez-Espigares, I. et al. GPCRmd uncovers the dynamics of the 3D-GPCRome. Nat. Methods 17(8), 777\u2013787. https:\/\/doi.org\/10.1038\/s41592-020-0884-y (2020).","journal-title":"Nat. Methods"},{"key":"3857_CR32","doi-asserted-by":"crossref","unstructured":"David, Aranda-Garc\u00eda Tomasz Maciej et al. Large scale investigation of GPCR molecular dynamics data uncovers allosteric sites and lateral gateways Nature Communications 16(1). https:\/\/doi.org\/10.1038\/s41467-025-57034-y  (2025).","DOI":"10.1038\/s41467-025-57034-y"},{"key":"3857_CR33","doi-asserted-by":"crossref","unstructured":"Dorota, Latek Khushil, Prajapati Paulina, Dragan Matthew, Merski Przemys\u0142aw, Osial (2025) GPCRVS - AI-driven Decision Support System for GPCR Virtual Screening International Journal of Molecular Sciences 26(5) 2160-10.3390\/ijms26052160","DOI":"10.3390\/ijms26052160"},{"key":"3857_CR34","doi-asserted-by":"publisher","unstructured":"Sanmukh, S. G., Krzykawska-Serda, M., Dragan, P., Baron, S., Lobaccaro, J.-M. A., & Latek, D. Is Cancer Our Equal or Our Better? Artificial Intelligence in Cancer Drug Discovery (Springer International Publishing, 2024). https:\/\/doi.org\/10.1007\/16833_2024_326.","DOI":"10.1007\/16833_2024_326"},{"issue":"4","key":"3857_CR35","doi-asserted-by":"publisher","first-page":"Article 4","DOI":"10.1038\/nsmb.3183","volume":"23","author":"J Yin","year":"2016","unstructured":"Yin, J. et al. Structure and ligand-binding mechanism of the human OX1 and OX2 orexin receptors. Nat. Struct. Mol. Biol. 23(4), Article 4. https:\/\/doi.org\/10.1038\/nsmb.3183 (2016).","journal-title":"Nat. Struct. Mol. Biol."},{"issue":"12","key":"3857_CR36","doi-asserted-by":"publisher","first-page":"1582","DOI":"10.1016\/j.str.2022.11.001","volume":"30","author":"H Asada","year":"2022","unstructured":"Asada, H. et al. Molecular basis for anti-insomnia drug design from structure of lemborexant-bound orexin 2 receptor. Structure 30(12), 1582-1589.e4. https:\/\/doi.org\/10.1016\/j.str.2022.11.001 (2022).","journal-title":"Structure"},{"issue":"12","key":"3857_CR37","doi-asserted-by":"publisher","first-page":"2609","DOI":"10.1021\/acs.jpcb.8b10220","volume":"123","author":"L Karhu","year":"2019","unstructured":"Karhu, L., Magarkar, A., Bunker, A. & Xhaard, H. Determinants of orexin receptor binding and activation\u2014a molecular dynamics study. J. Phys. Chem. B 123(12), 2609\u20132622. https:\/\/doi.org\/10.1021\/acs.jpcb.8b10220 (2019).","journal-title":"J. Phys. Chem. B"},{"key":"3857_CR38","doi-asserted-by":"publisher","DOI":"10.1016\/j.cophys.2024.100779","volume":"41","author":"P Dragan","year":"2024","unstructured":"Dragan, P. & Latek, D. The two-sided impact of beta-adrenergic receptor ligands on inflammation. Curr. Opin. Physiol. 41, 100779. https:\/\/doi.org\/10.1016\/j.cophys.2024.100779 (2024).","journal-title":"Curr. Opin. Physiol."},{"issue":"4","key":"3857_CR39","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0175642","volume":"12","author":"R Nehm\u00e9","year":"2017","unstructured":"Nehm\u00e9, R. et al. Mini-G proteins: Novel tools for studying GPCRs in their active conformation. PLoS ONE 12(4), e0175642. https:\/\/doi.org\/10.1371\/journal.pone.0175642 (2017).","journal-title":"PLoS ONE"},{"key":"3857_CR40","doi-asserted-by":"publisher","DOI":"10.1002\/0471250953.bi0506s15","author":"N Eswar","year":"2006","unstructured":"Eswar, N. et al. Comparative protein structure modeling using modeller. Curr. Protoc. Bioinform. https:\/\/doi.org\/10.1002\/0471250953.bi0506s15 (2006).","journal-title":"Curr. Protoc. Bioinform."},{"issue":"6006","key":"3857_CR41","doi-asserted-by":"publisher","first-page":"974","DOI":"10.1126\/science.1193438","volume":"330","author":"GL Waldo","year":"2010","unstructured":"Waldo, G. L. et al. Kinetic scaffolding mediated by a phospholipase C\u2013\u03b2 and Gq signaling complex. Science 330(6006), 974\u2013980. https:\/\/doi.org\/10.1126\/science.1193438 (2010).","journal-title":"Science"},{"issue":"D1","key":"3857_CR42","doi-asserted-by":"publisher","first-page":"D523","DOI":"10.1093\/nar\/gkac1052","volume":"51","author":"The UniProt Consortium","year":"2023","unstructured":"The UniProt Consortium. UniProt: The universal protein knowledgebase in 2023. Nucleic Acids Res. 51(D1), D523\u2013D531. https:\/\/doi.org\/10.1093\/nar\/gkac1052 (2023).","journal-title":"Nucleic Acids Res."},{"issue":"7953","key":"3857_CR43","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1038\/s41586-023-05789-z","volume":"615","author":"F Sadler","year":"2023","unstructured":"Sadler, F. et al. Autoregulation of GPCR signalling through the third intracellular loop. Nature 615(7953), 734\u2013741. https:\/\/doi.org\/10.1038\/s41586-023-05789-z (2023).","journal-title":"Nature"},{"issue":"2","key":"3857_CR44","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1093\/protein\/gzi004","volume":"18","author":"V-P Jaakola","year":"2005","unstructured":"Jaakola, V.-P., Prilusky, J., Sussman, J. L. & Goldman, A. G protein-coupled receptors show unusual patterns of intrinsic unfolding. Protein Eng. Des. Sel. 18(2), 103\u2013110. https:\/\/doi.org\/10.1093\/protein\/gzi004 (2005).","journal-title":"Protein Eng. Des. Sel."},{"issue":"5","key":"3857_CR45","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1016\/j.bbabio.2013.09.002","volume":"1837","author":"X Deupi","year":"2014","unstructured":"Deupi, X. Relevance of rhodopsin studies for GPCR activation. Biochim. Biophys. Acta BBA Bioenerget. 1837(5), 674\u2013682. https:\/\/doi.org\/10.1016\/j.bbabio.2013.09.002 (2014).","journal-title":"Biochim. Biophys. Acta BBA Bioenerget."},{"issue":"41","key":"3857_CR46","doi-asserted-by":"publisher","first-page":"28527","DOI":"10.1021\/jacs.4c11250","volume":"146","author":"X Qiu","year":"2024","unstructured":"Qiu, X. et al. Coupling and activation of the \u03b21 adrenergic receptor\u2014the role of the third intracellular loop. J. Am. Chem. Soc. 146(41), 28527\u201328537. https:\/\/doi.org\/10.1021\/jacs.4c11250 (2024).","journal-title":"J. Am. Chem. Soc."},{"issue":"11","key":"3857_CR47","doi-asserted-by":"publisher","first-page":"2507","DOI":"10.1110\/ps.062416606","volume":"15","author":"M Shen","year":"2006","unstructured":"Shen, M. & Sali, A. Statistical potential for assessment and prediction of protein structures. Protein Sci. Publ. Protein Soc. 15(11), 2507\u20132524. https:\/\/doi.org\/10.1110\/ps.062416606 (2006).","journal-title":"Protein Sci. Publ. Protein Soc."},{"key":"3857_CR48","unstructured":"The PyMOL Molecular Graphics System, Schr\u00f6dinger (Version 2.4.0). (n.d.). [Computer software]. Schr\u00f6dinger, LLC."},{"key":"3857_CR49","unstructured":"Maestro. (2022). [Computer software]. Schr\u00f6dinger, LLC."},{"issue":"1","key":"3857_CR50","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1021\/acs.jctc.5b00935","volume":"12","author":"J Lee","year":"2016","unstructured":"Lee, J. et al. CHARMM-GUI input generator for NAMD, GROMACS, AMBER, OpenMM, and CHARMM\/OpenMM simulations using the CHARMM36 additive force field. J. Chem. Theory Comput. 12(1), 405\u2013413. https:\/\/doi.org\/10.1021\/acs.jctc.5b00935 (2016).","journal-title":"J. Chem. Theory Comput."},{"issue":"27","key":"3857_CR51","doi-asserted-by":"publisher","first-page":"1997","DOI":"10.1002\/jcc.23702","volume":"35","author":"EL Wu","year":"2014","unstructured":"Wu, E. L. et al. CHARMM-GUI membrane builder toward realistic biological membrane simulations. J. Comput. Chem. 35(27), 1997\u20132004. https:\/\/doi.org\/10.1002\/jcc.23702 (2014).","journal-title":"J. Comput. Chem."},{"issue":"43","key":"3857_CR52","doi-asserted-by":"publisher","first-page":"12991","DOI":"10.1021\/jp309888u","volume":"116","author":"D Sengupta","year":"2012","unstructured":"Sengupta, D. & Chattopadhyay, A. Identification of cholesterol binding sites in the Serotonin1A receptor. J. Phys. Chem. B 116(43), 12991\u201312996. https:\/\/doi.org\/10.1021\/jp309888u (2012).","journal-title":"J. Phys. Chem. B"},{"issue":"4","key":"3857_CR53","doi-asserted-by":"publisher","DOI":"10.1063\/5.0014475","volume":"153","author":"JC Phillips","year":"2020","unstructured":"Phillips, J. C. et al. Scalable molecular dynamics on CPU and GPU architectures with NAMD. J. Chem. Phys. 153(4), 044130. https:\/\/doi.org\/10.1063\/5.0014475 (2020).","journal-title":"J. Chem. Phys."},{"key":"3857_CR54","unstructured":"Gullingsrud, J. (version 4.0). CatDCD (Version 4.0) [Computer software]. Theoretical and Computational Biophysics Group."},{"key":"3857_CR55","unstructured":"Giorgino, T., Henin, J., Lenz, O., Mura, C., & Saam, J. (version 2.7). PBCTools (Version 2.7) [Computer software]. Theoretical and Computational Biophysics Group."},{"issue":"1","key":"3857_CR56","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/0263-7855(96)00018-5","volume":"14","author":"W Humphrey","year":"1996","unstructured":"Humphrey, W., Dalke, A. & Schulten, K. VMD: Visual molecular dynamics. J. Mol. Graph. 14(1), 33\u201338. https:\/\/doi.org\/10.1016\/0263-7855(96)00018-5 (1996).","journal-title":"J. Mol. Graph."},{"issue":"2","key":"3857_CR57","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1124\/jpet.117.241422","volume":"362","author":"CT Beuckmann","year":"2017","unstructured":"Beuckmann, C. T. et al. In vitro and in silico characterization of lemborexant (E2006), a novel dual orexin receptor antagonist. J. Pharmacol. Exp. Ther. 362(2), 287\u2013295. https:\/\/doi.org\/10.1124\/jpet.117.241422 (2017).","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"21","key":"3857_CR58","doi-asserted-by":"publisher","first-page":"6071","DOI":"10.1016\/j.bmc.2014.08.034","volume":"22","author":"Y Yoshida","year":"2014","unstructured":"Yoshida, Y. et al. Design, synthesis, and structure\u2013activity relationships of a series of novel N-aryl-2-phenylcyclopropanecarboxamide that are potent and orally active orexin receptor antagonists. Bioorg. Med. Chem. 22(21), 6071\u20136088. https:\/\/doi.org\/10.1016\/j.bmc.2014.08.034 (2014).","journal-title":"Bioorg. Med. Chem."},{"issue":"11","key":"3857_CR59","doi-asserted-by":"publisher","first-page":"Article 11","DOI":"10.1038\/s41594-021-00674-7","volume":"28","author":"AS Hauser","year":"2021","unstructured":"Hauser, A. S. et al. GPCR activation mechanisms across classes and macro\/microscales. Nat. Struct. Mol. Biol. 28(11), Article 11. https:\/\/doi.org\/10.1038\/s41594-021-00674-7 (2021).","journal-title":"Nat. Struct. Mol. Biol."},{"issue":"8","key":"3857_CR60","doi-asserted-by":"publisher","first-page":"1090","DOI":"10.2174\/092986712799320556","volume":"19","author":"B Trzaskowski","year":"2012","unstructured":"Trzaskowski, B. et al. Action of molecular switches in GPCRs\u2014theoretical and experimental studies. Curr. Med. Chem. 19(8), 1090\u20131109. https:\/\/doi.org\/10.2174\/092986712799320556 (2012).","journal-title":"Curr. Med. Chem."},{"issue":"24","key":"3857_CR61","doi-asserted-by":"publisher","first-page":"6788","DOI":"10.1021\/acs.jcim.2c00635","volume":"62","author":"LR Kj\u00f8lbye","year":"2022","unstructured":"Kj\u00f8lbye, L. R. et al. Lipid modulation of a class B GPCR: elucidating the modulatory role of PI(4,5)P2 lipids. J. Chem. Inf. Model. 62(24), 6788\u20136802. https:\/\/doi.org\/10.1021\/acs.jcim.2c00635 (2022).","journal-title":"J. Chem. Inf. Model."},{"issue":"1","key":"3857_CR62","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsb.2020.107694","volume":"213","author":"D Ham","year":"2021","unstructured":"Ham, D. et al. Conformational switch that induces GDP release from Gi. J. Struct. Biol. 213(1), 107694. https:\/\/doi.org\/10.1016\/j.jsb.2020.107694 (2021).","journal-title":"J. Struct. Biol."},{"issue":"7","key":"3857_CR63","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pcbi.1002595","volume":"8","author":"M Louet","year":"2012","unstructured":"Louet, M., Martinez, J. & Floquet, N. GDP release preferentially occurs on the phosphate side in heterotrimeric G-proteins. PLoS Comput. Biol. 8(7), e1002595. https:\/\/doi.org\/10.1371\/journal.pcbi.1002595 (2012).","journal-title":"PLoS Comput. Biol."},{"issue":"3","key":"3857_CR64","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1152\/physrev.00021.2020","volume":"101","author":"D Calebiro","year":"2021","unstructured":"Calebiro, D., Koszegi, Z., Lanoisel\u00e9e, Y., Miljus, T. & O\u2019Brien, S. G protein-coupled receptor-G protein interactions: A single-molecule perspective. Physiol. Rev. 101(3), 857\u2013906. https:\/\/doi.org\/10.1152\/physrev.00021.2020 (2021).","journal-title":"Physiol. Rev."},{"issue":"6563","key":"3857_CR65","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1038\/379311a0","volume":"379","author":"DG Lambright","year":"1996","unstructured":"Lambright, D. G. et al. The 2.0 \u00c5 crystal structure of a heterotrimeric G protein. Nature 379(6563), 311\u2013319. https:\/\/doi.org\/10.1038\/379311a0 (1996).","journal-title":"Nature"},{"issue":"6","key":"3857_CR66","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.1016\/0092-8674(95)90220-1","volume":"83","author":"MA Wall","year":"1995","unstructured":"Wall, M. A. et al. The structure of the G protein heterotrimer Gi\u03b11\u03b21\u03b32. Cell 83(6), 1047\u20131058. https:\/\/doi.org\/10.1016\/0092-8674(95)90220-1 (1995).","journal-title":"Cell"},{"issue":"226","key":"3857_CR67","doi-asserted-by":"publisher","first-page":"re2","DOI":"10.1126\/scisignal.2003013","volume":"5","author":"HG Dohlman","year":"2012","unstructured":"Dohlman, H. G. & Jones, J. C. Signal activation and inactivation by the G\u03b1 helical domain: A long-neglected partner in G protein signaling. Sci. Signal. 5(226), re2. https:\/\/doi.org\/10.1126\/scisignal.2003013 (2012).","journal-title":"Sci. Signal."},{"issue":"D1","key":"3857_CR68","doi-asserted-by":"publisher","first-page":"D518","DOI":"10.1093\/nar\/gkab852","volume":"50","author":"G P\u00e1ndy-Szekeres","year":"2022","unstructured":"P\u00e1ndy-Szekeres, G. et al. The G protein database, GproteinDb. Nucleic Acids Res. 50(D1), D518\u2013D525. https:\/\/doi.org\/10.1093\/nar\/gkab852 (2022).","journal-title":"Nucleic Acids Res."},{"key":"3857_CR69","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.38465","volume":"7","author":"X Sun","year":"2018","unstructured":"Sun, X., Singh, S., Blumer, K. J. & Bowman, G. R. Simulation of spontaneous G protein activation reveals a new intermediate driving GDP unbinding. Elife 7, e38465. https:\/\/doi.org\/10.7554\/eLife.38465 (2018).","journal-title":"Elife"},{"issue":"7711","key":"3857_CR70","doi-asserted-by":"publisher","first-page":"Article 7711","DOI":"10.1038\/s41586-018-0215-y","volume":"558","author":"Y Kang","year":"2018","unstructured":"Kang, Y. et al. Cryo-EM structure of human rhodopsin bound to an inhibitory G protein. Nature 558(7711), Article 7711. https:\/\/doi.org\/10.1038\/s41586-018-0215-y (2018).","journal-title":"Nature"},{"issue":"6241","key":"3857_CR71","doi-asserted-by":"publisher","first-page":"1361","DOI":"10.1126\/science.aaa5264","volume":"348","author":"RO Dror","year":"2015","unstructured":"Dror, R. O. et al. Structural basis for nucleotide exchange in heterotrimeric G proteins. Science 348(6241), 1361\u20131365. https:\/\/doi.org\/10.1126\/science.aaa5264 (2015).","journal-title":"Science"},{"key":"3857_CR72","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.sbi.2021.03.013","volume":"69","author":"D Ahn","year":"2021","unstructured":"Ahn, D., Ham, D. & Chung, K. Y. The conformational transition during G protein-coupled receptor (GPCR) and G protein interaction. Curr. Opin. Struct. Biol. 69, 117\u2013123. https:\/\/doi.org\/10.1016\/j.sbi.2021.03.013 (2021).","journal-title":"Curr. Opin. Struct. Biol."},{"key":"3857_CR73","doi-asserted-by":"publisher","unstructured":"Tyson, A. S., et al. Molecular mechanisms of inverse agonism via \u03ba-opioid receptor\u2013G protein complexes. Nat. Chem. Biol. 1\u201312. https:\/\/doi.org\/10.1038\/s41589-024-01812-0 (2025).","DOI":"10.1038\/s41589-024-01812-0"},{"issue":"17","key":"3857_CR74","doi-asserted-by":"publisher","first-page":"13430","DOI":"10.3390\/ijms241713430","volume":"24","author":"MRPD Lima","year":"2023","unstructured":"Lima, M. R. P. D., Bezerra, R. F. S., Serafim, D. D. B. & Sena Junior, D. M. Dynamics of the Apo \u00b5-opioid receptor in complex with Gi protein. Int. J. Mol. Sci. 24(17), 13430. https:\/\/doi.org\/10.3390\/ijms241713430 (2023).","journal-title":"Int. J. Mol. Sci."},{"issue":"6","key":"3857_CR75","doi-asserted-by":"publisher","first-page":"415","DOI":"10.5483\/BMBRep.2008.41.6.415","volume":"41","author":"P-G Suh","year":"2008","unstructured":"Suh, P.-G. et al. Multiple roles of phosphoinositide-specific phospholipase C isozymes. BMB Rep. 41(6), 415\u2013434. https:\/\/doi.org\/10.5483\/BMBRep.2008.41.6.415 (2008).","journal-title":"BMB Rep."},{"issue":"19","key":"3857_CR76","doi-asserted-by":"publisher","first-page":"16379","DOI":"10.1074\/jbc.M006617200","volume":"276","author":"LA Sellers","year":"2001","unstructured":"Sellers, L. A. et al. Adenosine nucleotides acting at the human P2Y1 receptor stimulate mitogen-activated protein kinases and induce apoptosis. J. Biol. Chem. 276(19), 16379\u201316390. https:\/\/doi.org\/10.1074\/jbc.M006617200 (2001).","journal-title":"J. Biol. Chem."},{"issue":"5","key":"3857_CR77","doi-asserted-by":"publisher","first-page":"527","DOI":"10.2174\/156652409788488784","volume":"9","author":"V Yanamadala","year":"2009","unstructured":"Yanamadala, V., Negoro, H. & Denker, B. Heterotrimeric G proteins and apoptosis: intersecting signaling pathways leading to context dependent phenotypes. Curr. Mol. Med. 9(5), 527\u2013545. https:\/\/doi.org\/10.2174\/156652409788488784 (2009).","journal-title":"Curr. Mol. Med."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-03857-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-03857-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-03857-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,19]],"date-time":"2025-11-19T08:26:09Z","timestamp":1763540769000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-03857-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,22]]},"references-count":77,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3857"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-03857-0","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,22]]},"assertion":[{"value":"10 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 September 2025","order":5,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Update","order":6,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The original online version of this Article was revised: The accompanying Supplementary Information files have been updated.","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"30899"}}